Crossmark

A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis

Published Online: 2020-11-26

Published Print: 2021-03

Authors

Edwards, Christopher J.

Sawant, Ruta

Garg, Vishvas

Du, Ella X.

Friedman, Alan

Betts, Keith A.
Funding

Funding for this research was provided by:

AbbVie
License Information

Text and Data Mining valid from 2020-11-26

Version of Record valid from 2020-11-26
More Information

Article History

Received: 5 October 2020

Accepted: 10 November 2020

First Online: 26 November 2020

Document is current